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Abstract
Background: Urine output is widely used as one of the criteria for the diagnosis and staging of acute renal failure,
but few studies have specifically assessed the role of oliguria as a marker of acute renal failure or outcomes in
general intensive care unit (ICU) patients. Using a large multinational database, we therefore evaluated the
occurrence of oliguria (defined as a urine output < 0.5 ml/kg/h) in acutely ill patients and its association with the
need for renal replacement therapy (RRT) and outcome.
Methods: International observational study. All adult (> 16 years) patients in the ICON audit who had a urine output
measurement on the day of admission were included. To investigate the association between oliguria and
mortality, we used a multilevel analysis.
Results: Of the 8292 patients included, 2050 (24.7%) were oliguric during the first 24 h of admission. Patients with
oliguria on admission who had at least one additional 24-h urine output recorded during their ICU stay (n = 1349)
were divided into three groups: transient—oliguria resolved within 48 h after the admission day (n = 390 [28.9%]),
prolonged—oliguria resolved > 48 h after the admission day (n = 141 [10.5%]), and permanent—oliguria persisting
for the whole ICU stay or again present at the end of the ICU stay (n = 818 [60.6%]). ICU and hospital mortality rates
were higher in patients with oliguria than in those without, except for patients with transient oliguria who had
significantly lower mortality rates than non-oliguric patients. In multilevel analysis, the need for RRT was associated
with a significantly higher risk of death (OR = 1.51 [95% CI 1.19–1.91], p = 0.001), but the presence of oliguria on
admission was not (OR = 1.14 [95% CI 0.97–1.34], p = 0.103).
Conclusions: Oliguria is common in ICU patients and may have a relatively benign nature if only transient. The
duration of oliguria and need for RRT are associated with worse outcome.
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Introduction
Regardless of the exact criteria used to define it, oliguria
is often observed in critically ill patients, and yet there
are many questions regarding its clinical relevance and
impact on outcomes. Reduced urine output can be a
physiological response or a reflection of altered tissue
perfusion or renal dysfunction [1–3].
Although urine output is now widely used as one of
the criteria for the diagnosis and staging of acute renal
failure [4–7], there are relatively few studies that have
specifically assessed urine output or oliguria as a marker
of acute renal failure or outcomes in general populations
of intensive care unit (ICU) patients [2, 8, 9]. The clin-
ical importance of oliguria likely depends on its dur-
ation. For example, a 1-h period of oliguria during an
emergency admission is less important than if the symp-
tom persists for longer periods, when it is more likely to
reflect impaired renal function [10, 11].
To provide some global insight into the impact of oli-
guria and its persistence on outcomes in general ICU pa-
tients, we reviewed the large, international Intensive
Care over Nations (ICON) database to evaluate the oc-
currence of oliguria and its association with the need for
renal replacement therapy (RRT) and mortality.
Patients and methods
This study is a substudy of the ICON audit [12]. All
adult (> 16 years) patients admitted to a participating
ICU (see the list in the “Acknowledgements”) between
May 8 and May 18, 2012, were included in the audit, ex-
cept those who stayed in the ICU for < 24 h for routine
postoperative surveillance. Participation was voluntary,
with no financial incentive. Ethics committee approval
was obtained by the participating institutions according
to local ethical regulations.
Data were collected daily for a maximum of 28 days in
the ICU and entered using electronic case report forms
via a secured internet-based website. Survival data were
collected at the time of ICU and hospital discharge, or at
60 days, whichever occurred first. Detailed instructions
and definitions were available through a secured website
for all participants before starting data collection and
throughout the study period. Any additional queries
were answered on a per case basis. Validity checks were
made at the time of electronic data entry, including
plausibility checks within each variable and between var-
iables. Data were further reviewed by the coordinating
center for completeness and plausibility, and any doubts
clarified with the participating center. There was no on-
site monitoring.
Data collection on admission included demographic
data and comorbidities. Clinical and laboratory data for
the SAPS II score [13] were reported as the worst values
within the first 24 h after admission. A daily evaluation
of organ function was performed according to the Se-
quential Organ Failure Assessment (SOFA) score [5];
organ failure was defined as a SOFA subscore > 2 for the
organ in question. ICU interventions, including RRT and
mechanical ventilation, were recorded daily.
Clinical and microbiologically proven infections were
reported daily as well as antimicrobial therapy. Infection
was defined according to the criteria of the International
Sepsis Forum [14]. Sepsis was defined as the presence of
infection with associated organ failure [15]. Septic shock
was defined as sepsis associated with cardiovascular fail-
ure requiring vasopressor support (SOFA cardiovascular
score ≥ 3). The presence of a decision to withhold/with-
draw a life-sustaining measure at any time during the
ICU stay was also recorded.
On the case report form, investigators recorded
urine output in milliliters as a total for each 24-h
period. On the day of admission, urine output data
were recorded for the period from the time of admis-
sion till the start of the next ICU day. For the pur-
poses of this study, oliguria was defined as a
calculated urine output < 0.5 ml/kg/h averaged over a
24-h period [2]. To calculate the urine output for the
24-h admission day period, if full urine output data
for the first 24 h of admission were recorded, these
data were used for the determination of oliguria “on
admission.” If data were provided for only X hours on
the day of admission (because, for example, the pa-
tient was admitted at 10 pm and 24-h urine measure-
ment started at midnight so only 2-h urine output
were noted), the estimation of urine output on admis-
sion was averaged from the data for the X hours and
the data from the first full day on the ICU (2nd day
24-h urine output/24 × [24 − X]). If no data were re-
corded for the admission day, we were unable to esti-
mate an admission urine output and the patient was
not included. The methods of measuring urine output
or of assessing body weight were not recorded. Pa-
tients with comorbid chronic renal failure were
excluded.
For analysis of evolution during the ICU stay, we in-
cluded only patients who had a urine output recorded
on the day of admission and at least one other 24-h
urine output value, and separated them into three
groups:
 Transient oliguria—oliguria resolved within 48 h
after the 24-h admission day
 Prolonged oliguria—oliguria resolved more than 48
h after the 24-h admission day and not present at
the end of the ICU stay
 Permanent oliguria—oliguria present on the day of
admission and persisting for the whole ICU stay or
again present at the end of the ICU stay
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Statistical analysis
Data are shown as means with standard deviation (SD)
or 95% confidence intervals (CI), medians and interquar-
tile ranges (IQR), numbers, and percentages. For the de-
scriptive statistics, only available data were used so
missing data were subtracted from the denominator
when calculating percentages. Differences between
groups in distribution of variables were assessed using
the analysis of variance (ANOVA), Kruskal-Wallis test,
Student’s t test, Mann-Whitney test, chi-square test, or
Fisher’s exact test as appropriate.
Individual countries were classified into three income
groups according to the 2011 gross national income
(GNI) per capita, calculated using the World Bank Atlas
method [16]: GNI < $4035 = low and lower middle in-
come, GNI $4036–12,475 = upper middle income, and
GNI > $12,476 = high income.
To investigate the association between oliguria on ad-
mission and mortality, we used a three-level technique
with the structure of an individual patient (level 1) ad-
mitted to a specific hospital (level 2) within a particular
country (level 3). So patients were nested within hospi-
tals within countries. The model includes hospital and
country units as random effects to express the concept
that patients from the same country and treated in the
same hospital share a common environment. The de-
pendency between patients in a hospital within a country
is captured through the use of random intercepts. The
explanatory variables considered in the model were:
– Individual-level factors: age, sex, SAPS II score, type
of admission, source of admission, highest
concentration of creatinine, daily fluid balance,
mechanical ventilation or RRT at any time during
the ICU stay, fluid balance, presence of recorded
end-of-life decision, comorbidities, severity of sepsis
during the ICU stay, oliguria on admission
– Hospital-level factors: type of hospital, ICU specialty,
total number of ICU patients in the previous year,
number of staffed ICU beds
– Country-level factors: GNI
Collinearity between variables was checked by inspec-
tion of the correlation between them, by looking at the
correlation matrix of the estimated parameters, and by
looking at the change in parameter estimates and at their
estimated standard errors [17]. Q-Q plots were drawn to
check for normality in the residuals. The results of fixed
effects (measures of association) are given as odds ratios
(OR) with their 95% CI. Random effects (measures of vari-
ation) measures included the variance (var) and its stand-
ard error (se). The restricted maximum likelihood (REML)
procedure, which gives unbiased estimates of the model
parameters, was used. The Wald test was used to assess
the significance of included covariates. The percentage of
cases correctly classified and the area under the receiver
operating characteristic curve (AUC) are given to quantify
the discriminating power of the model. Missing cases for
the included variables were analyzed using the missing-
value indicator method.
Data were analyzed using IBM® SPSS® Statistics soft-
ware, version 26 for Windows and R software, version
3.6.1 (CRAN project). All reported p values are two-
sided, and a p value < 0.05 was considered to indicate
statistical significance.
Results
Of the 10,069 patients included in the ICON audit, 9148
had urine output data on the day of admission; 856 had
comorbid chronic renal failure and were excluded, leav-
ing 8292 patients for analysis (Fig. 1).
Patients with oliguria on admission
A total of 2050 (24.7%) patients had oliguria on the 24-h
admission period, with a median urine output of 0.3
[IQR 0.1–0.4] ml/kg/h compared to 1.1 [IQR 0.8–1.6]
ml/kg/h in patients who were not oliguric on admission
(p < 0.001) (Table 1). Patients with oliguria on admis-
sion were older and more severely ill than those without,
and a higher proportion had a medical diagnosis and co-
morbid heart failure, liver cirrhosis, and human im-
munodeficiency virus (HIV) infection (Table 1). They
were more likely to have sepsis (24.5% vs 16.7%,
p < 0.001) and to have all forms of organ failure, except
hepatic (Table 1). Vasopressor use was higher in patients
with oliguria at admission than in those without (36.9%
vs 26.8%, p < 0.001).
ICU (26.8% vs 11.5%, p < 0.001) and hospital (34.5%
vs 16.7%, p < 0.001) mortality rates were more than
twice as high in patients with oliguria on admission than
in those without (Table 1). End-of-life decisions were
more common in oliguric patients than in the other pa-
tients (Table 2).
RRT was needed at some point during the ICU stay in
442 (21.6%) of the patients with and in 407 (6.5%) of the
patients without oliguria on admission (p < 0.001)
(Table 2). Multilevel analysis revealed that the need for
RRT was associated with a statistically significant in-
creased risk of death (OR = 1.51 [95% CI 1.19–1.91], p =
0.001), but the presence of oliguria on admission was
not (OR = 1.14 [95% CI 0.97–1.34], p = 0.103) (Table 3).
After controlling for patient and hospital factors and
GNI, there was significant between-hospital (var = 0.5
[se = 0.09], p < 0.001) and between-country (var = 0.23
[se = 0.08], p = 0.004) variation in risks of in-hospital
death (Table 3), indicating that the occurrence of in-
hospital death was influenced by both hospital- and
country-related factors.
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Persistence of oliguria during ICU stay
A total of 1349 patients had at least one additional urine
output measurement recorded during their ICU stay. Oli-
guria was transient in 390 (28.9%) of these patients, pro-
longed in 141 (10.5%), and permanent in 818 (60.6%)
(Table 4). ICU mortality was 7.1% when oliguria was tran-
sient, significantly lower than in the patients without oli-
guria (11.5%, p = 0.037); rates were 10.9% when oliguria
was prolonged and 28.9% when permanent (Table 4).
RRT was used in the ICU in 48 (12.3%), 63 (44.7%),
and 273 (33.4%) patients with transient, prolonged, and
permanent oliguria, respectively; 102 (19%) patients with
permanent oliguria died in the ICU without receiving
RRT. RRT was started within 24 h in 72.4% of patients
with oliguria (75.0% vs 73.0% vs 71.8% in patients with
transient, prolonged, and permanent oliguria, respect-
ively). Among patients receiving RRT, ICU mortality was
higher in non-oliguric patients than in those with
Fig. 1 Flow chart of patients included in study
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Table 1 Characteristics of the study cohort on admission to the ICU stratified according to whether or not oliguria was present
All patients
n = 8292 Oliguria at admission
p value
No
n = 6242 (75.3%)
Yes
n = 2050 (24.7)
Urine output (ml/kg/h) median [IQR] 0.9 [0.5–1.4] 1.1 [0.8–1.6] 0.3 [0.1–0.4] < 0.001
Age, years, mean ± SD 59.2 ± 18.2 58.1 ± 18.3 62.5 ± 17.4 < 0.001
Male, n (%) 4928 (60.0) 3724 (60.2) 1204 (59.4) 0.55
Severity scores, mean ± SD
SAPS II score 40.8 ± 17.5 37.9 ± 15.1 49.8 ± 20.8 < 0.001
SOFA score at admission 6.2 ± 4.2 5.7 ± 3.8 7.6 ± 5.0 < 0.001
SOFA score at admission (without renal subscore) 5.3 ± 3.7 5.1 ± 3.5 5.8 ± 4.2 < 0.001
Type of admission, n (%)
Surgical (non-trauma) 2939 (37.2) 2374 (39.9) 565 (29.2) < 0.001
Medical 4335 (54.9) 3063 (51.4) 1272 (65.7)
Trauma 569 (7.2) 478 (8.0) 91 (4.7)
Other 48 (.6) 40 (.7) 8 (.4)
Source of admission, n (%)
Other hospital 825 (9.9) 625 (10.0) 200 (9.8) < 0.01
ER/ambulance 3151 (38.0) 2336 (37.4) 815 (39.8)
OR/recovery room 1569 (18.9) 1304 (20.9) 265 (12.9)
Hospital floor 2117 (25.5) 1529 (24.5) 588 (28.7)
Other 630 (7.6) 448 (7.2) 182 (8.9)
Comorbidities, n (%)
COPD 1012 (12.2) 737 (11.8) 275 (13.4) 0.06
Cancer 891 (10.7) 684 (11.0) 207 (10.1) 0.29
Metastatic cancer 288 (3.5) 205 (3.3) 83 (4.0) 0.11
Hematologic cancer 178 (2.1) 126 (2.0) 52 (2.5) 0.16
Insulin 682 (8.2) 496 (7.9) 186 (9.1) 0.12
Heart failure, NYHA III/IV 648 (7.8) 445 (7.1) 203 (9.9) < 0.001
HIV infection 56 (.7) 33 (.5) 23 (1.1) < 0.01
Cirrhosis 283 (3.4) 188 (3.0) 95 (4.6) < 0.001
Immunosuppression 259 (3.1) 184 (2.9) 75 (3.7) 0.11
Steroid therapy 273 (3.3) 208 (3.3) 65 (3.2) 0.78
Chemotherapy 239 (2.9) 181 (2.9) 58 (2.8) 0.94
Organ support, n (%)
Mechanical ventilation 4227 (51.0) 3184 (51.0) 1043 (50.9) 0.92
Renal replacement therapy 321 (3.9) 97 (1.6) 224 (10.9) < 0.001
Vasopressor use 2429 (29.3) 1672 (26.8) 757 (36.9) < 0.001
Type of organ failure, n (%) (alone or in combination)
Respiratory 1867 (22.5) 1334 (21.4) 533 (26.0) < 0.001
Coagulation 530 (6.4) 345 (5.5) 185 (9.0) < 0.001
Hepatic 885 (10.7) 658 (10.5) 227 (11.1) 0.51
CNS 1972 (23.8) 1435 (23.0) 537 (26.2) < 0.01
Renal 1341 (16.2) 524 (8.4) 817 (39.9) < 0.001
Cardiovascular 2296 (27.7) 1580 (25.3) 716 (34.9) < 0.001
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transient or prolonged oliguria but lower than in those
with permanent oliguria (Table 4). The maximum serum
creatinine concentration was higher in patients with pro-
longed and permanent oliguria than in those with transi-
ent oliguria (Table 4). The mean daily fluid balance
during the ICU stay was significantly higher in patients
with permanent oliguria than in those with transient or
prolonged oliguria (Table 4).
Discussion
The present study in a large cohort of ICU patients with
urine outputs measured on admission and during the
Table 1 Characteristics of the study cohort on admission to the ICU stratified according to whether or not oliguria was present
(Continued)
All patients
n = 8292 Oliguria at admission
p value
No
n = 6242 (75.3%)
Yes
n = 2050 (24.7)
Number of organ failures, n (%)
None 1771 (21.4) 1489 (23.9) 282 (13.8) < 0.001
1 organ 2344 (28.3) 1805 (28.9) 539 (26.3)
2 organs 1693 (20.4) 1302 (20.9) 391 (19.1)
3 organs 1231 (14.8) 883 (14.1) 348 (17.0)
> 3 organs 1253 (15.1) 763 (12.2) 490 (23.9)
Sepsis, n (%) 1543 (18.6) 1041 (16.7) 502 (24.5) < 0.001
ICU stay, median [IQR] 3.0 [2.0–6.0] 3.0 [2.0–6.0] 3.0 [1.0–7.0] < 0.001
In survivors 3.0 [1.0–6.0] 3.0 [1.0–6.0] 3.0 [0.0–7.0] 0.046
In non-survivors 3.0 [0.0–8.0] 5.0 [1.0–10.0] 2.0 [0.0–6.0] < 0.001
Hospital stay, median [IQR] 10.0 [5.0–20.0] 10.0 [6.0–20.0] 8.0 [2.0–18.0] < 0.001
In survivors 11.0 [2.0–21.0] 11.0 [2.0–21.0] 11.0 [1.0–22.0] 0.075
In non-survivors 5.0 [0.0–14.0] 7.0 [1.0–15.0] 3.0 [0.0–10.0] < 0.001
ICU mortality, n (%) 1234 (15.2) 700 (11.5) 534 (26.8) < 0.001
Hospital mortality, n (%) 1649 (21.1) 983 (16.7) 666 (34.5) < 0.001
SD standard deviation, SAPS II Simplified Acute Physiology Score II, SOFA Sequential Organ Failure Assessment, ER emergency room, OR operating room, COPD
chronic obstructive pulmonary disease, NYHA New York Heart Association, HIV human immunodeficiency virus, CNS central nervous system, ICU intensive care
unit, IQR interquartile range. Percentages are calculated after excluding missing data
Table 2 Interventions and occurrence of sepsis during the ICU stay
All patients
n = 8292
Oliguria p
valueNo
n = 6242 (75.3%)
Yes
n = 2050 (24.7%)
Creatinine, highest concentration (mg/dl), median [IQR] 1.0 [0.8–1.5] 0.9 [0.7–1.3] 1.3 [0.9–2.4] < 0.001
Daily fluid balancea, ml, median [IQR] 81.0 [− 504.1–730.4] 3.3 [− 612–605.7] 356.3 [− 153.2–1116.7] < 0.001
Mechanical ventilation, n (%) 4769 (57.5) 3579 (57.3) 1190 (58.0) 0.59
RRT, n (%) 849 (10.2) 407 (6.5) 442 (21.6) < 0.001
Hemofiltration, n (%) 590 (7.1) 268 (4.3) 322 (15.7) < 0.001
Hemodialysis, n (%) 551 (6.6) 266 (4.3) 285 (13.9) < 0.001
Sepsis severity, n (%)
No sepsis 5718 (69) 4403 (70.5) 1315 (64.1) < 0.001
Sepsis 1104 (13.3) 858 (13.7) 246 (12.0)
Shock 1470 (17.7) 981 (15.7) 489 (23.9)
Decision to withhold/withdraw life-sustaining therapy, n (%) 1068 (12.9) 728 (11.7) 340 (16.6) < 0.001
aTotal fluid balance divided by the length of ICU stay. RRT renal replacement therapy
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ICU stay reveals that oliguria is present in about one
fourth of critically ill patients on admission to the ICU.
The presence of oliguria on admission was not inde-
pendently associated with an increased risk of death, but
the persistence of oliguria during the ICU stay was asso-
ciated with higher ICU and hospital mortality rates.
There are relatively few published data on the frequency
of oliguria in general ICU patients. Oliguria is frequently
observed in the perioperative period and may be the con-
sequence of hypovolemia and/or pain, both triggering the
sympathetic nervous system, which in turn lead to activa-
tion of the renin-angiotensin-aldosterone system with en-
suing oliguria. However, oliguria may also represent a
warning of deteriorating renal function, especially in crit-
ically ill patients. Macedo et al. reported that 47% of their
cohort of 317 surgical ICU patients had an episode of oli-
guria (urine output < 0.5 ml/kg/h for at least 6 consecutive
Table 3 Multilevel analysis of factors associated with hospital
mortality
Variables OR (95% CI) p value
Fixed effects, varying within clusters
Age 1.00 (1.00–1.01) 0.19
Sex, male 0.99 (0.85–1.14) 0.848
SAPS II 1.05 (1.05–1.06) < 0.001
Type of admission (%)
Surgical Ref na
Medical 1.53 (1.26–1.86) < 0.001
Trauma 1.53 (1.14–2.05) 0.004
Other 1.92 (0.71–5.17) 0.196
Source of admission
OR/recovery Ref na
Other hospital 1.17 (0.81–1.68) 0.404
ER/ambulance 1.12 (0.84–1.49) 0.458
Hospital floor 1.65 (1.26–2.16) < 0.001
Other 1.20 (0.81–1.80) 0.366
Comorbidities
COPD 0.98 (0.73–1.31) 0.877
Cancer 1.41 (1.15–1.74) 0.001
Metastatic cancer 1.20 (0.86–1.67) 0.281
Hematologic cancer 1.75 (1.25–2.44) 0.001
Insulin 0.84 (0.64–1.09) 0.189
Heart failure, NYHA III/IV 1.54 (1.19–1.99) 0.001
HIV infection 0.73 (0.27–1.94) 0.523
Cirrhosis 2.12 (1.45–3.10) < 0.001
Immunosuppression 1.19 (0.78–1.79) 0.419
Steroid therapy 1.17 (0.74–1.84) 0.497
Chemotherapy 0.92 (0.55–1.53) 0.748
Creatinine, highest [mg/dl] 1.00 (0.97–1.02) 0.796
Daily fluid balancea [l] 1.37 (1.25–1.50) < 0.001
Procedures during the ICU stay
Mechanical ventilation 2.66 (2.12–3.34) < 0.001
Renal replacement therapy 1.51 (1.19–1.91) 0.001
Severity of sepsis
No sepsis Ref na
Sepsis without shock 0.98 (0.75–1.28) 0.887
Septic shock 1.55 (1.25–1.92) < 0.001
End-of-life decision 11.82 (6.70–20.84) < 0.001
Oliguria on admission 1.14 (0.97–1.34) 0.103
Fixed effects, constant within clusters
Type of hospital
University/academic Ref na
Non-university 1.16 (0.88–1.52) 0.293
Table 3 Multilevel analysis of factors associated with hospital
mortality (Continued)
Variables OR (95% CI) p value
Number of patients admitted to the ICU (in 2011)
750+ Ref na
500–749 0.95 (0.76–1.19) 0.663
250–499 0.95 (0.68–1.31) 0.746
< 250 1.21 (0.77–1.91) 0.415
ICU specialty
Surgical Ref na
Medical 0.63 (0.38–1.04) 0.072
Mixed 0.73 (0.54–1.00) 0.047
Others 0.94 (0.58–1.52) 0.79
Staffed ICU beds
15+ Ref na
< 15 1.12 (0.87–1.44) 0.397
Income
High Ref na
Upper middle 1.81 (1.20–2.73) 0.005
Low and lower middle 2.05 (1.37–3.08) 0.001
Random effects
Country
Variance (se) 0.23 (0.08)
p value 0.004
Hospital within country
Variance (se) 0.50 (0.09)
p value < 0.001
aTotal fluid balance divided by the length of ICU stay
OR odds ratio, SAPS II Simplified Acute Physiology Score II, ER emergency
room, OR operating room, COPD chronic obstructive pulmonary disease, NYHA
New York Heart Association, HIV human immunodeficiency virus. The
percentage of cases correctly classified with this model is 88.6%. The AUC is
91.5% (95% CI 90.7–92.3%)
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hours) during the ICU stay [1]. In an analysis of data from
the FINNAKI study, as many as 92% of patients had an
episode of oliguria as defined by a urine output < 0.5 ml/
kg/h for a minimum of 0.5 h [3]. From their large data-
base, Kellum et al. reported that 59% of ICU patients with
acute kidney injury (AKI) met the KDIGO urine output
criteria [8]. In a smaller cohort, Md Ralib et al. reported
that 61% of patients with AKI met urine output criteria (<
0.5 ml/kg/h) [11], and in a study of critically ill cancer pa-
tients, 56% met urine output criteria for AKI [18].
The mortality rate was higher in patients with oliguria
than in those without. In an analysis of 21,207 ICU pa-
tients from the large MIMIC-II database, Zhang et al.
similarly reported increased mortality in patients with oli-
guria on day 1 [19]. However, oliguria may be an epiphe-
nomenon of or surrogate for disease severity and after
adjusting for multiple factors in the multilevel analysis, oli-
guria on admission was not independently associated with
increased mortality in our patients. Importantly, we also
analyzed the persistence of oliguria during the ICU stay
and noted that ICU mortality rates in patients with transi-
ent oliguria were significantly lower than those in non-
oliguric patients. Indeed, ICU and hospital mortality rates
were lower in these patients with transient oliguria than in
the overall ICON cohort (ICU 16.2%, hospital 22.4%, both
p < 0.001) [12]. Our results therefore highlight that the
duration of oliguria seems to be more important than the
presence of oliguria per se. Macedo et al. similarly re-
ported that prolonged duration of oliguria (> 12 h) was as-
sociated with increased mortality [1]. Vaara et al. [3]
reported that 6–12 h of oliguria (0.3 to < 0.5ml/kg/h), > 6
h of oliguria (0.1 to < 0.3 ml/kg/h), and severe oliguria
(< 0.1ml/kg/h) lasting > 3 h were independently associated
with increased 90-day mortality. In an earlier analysis of
the ICON database, patients who remained in stage 3 AKI
(defined using the AKIN urine output or creatinine cri-
teria) for a 7-day period had higher mortality rates than
those in whom renal function recovered [20]. Prowle et al.
[2] noted that although oliguria of longer than 1 h was sig-
nificantly associated with the subsequent development of
AKI diagnosed using creatinine criteria, short periods
(1–6 h) of oliguria were not accurate at predicting AKI. In
a cohort of patients undergoing major abdominal surgery,
the presence of oliguria (urine output < 0.3ml/kg/h)
during surgery was indicative of an elevated probability of
later AKI [21]. Similar results were recently published by
Myles et al. [22] when a urine output < 0.5ml/kg/h was
used to define oliguria.
Our data also suggest that the increased mortality may
be related more to the need for RRT than the oliguria it-
self, suggesting that other parameters, for example, high
serum creatinine concentrations, may be better indica-
tors for RRT than urine output. In an analysis of the
MIMIC-II database, Mandelbaum et al. [9] reported that
the increase in serum creatinine was a better predictor
of the need for RRT than urine output, although urine
output was a slightly better predictor of mortality. In
their analysis, Kellum et al. reported that RRT use was
more likely in patients diagnosed with AKI using urine
output and creatinine concentration criteria than in pa-
tients diagnosed with AKI using just one of the two cri-
teria [8]. We did not use the AKI criteria, preferring to
Table 4 Creatinine concentrations, fluid balance, renal replacement therapy, and mortality rates in patients with transient,
prolonged, and permanent oliguria
Non-oliguric on
admission
n = 6242
Oliguria during ICU stay, n = 1349 p value
(across
groups)
Transient
n = 390 (28.9%)
Prolonged
n = 141 (10.5%)
Permanent
n = 818 (60.6%)
SAPS II score, mean ± SD 37.9 ± 15.1 47.1 ± 16.7£ 54.4 ± 17*,£ 49.7 ± 18.8$,£ < 0.001
Creatinine, highest concentration (mg/dl), median
[IQR]
0.9 [0.7–1.3] 1.2 [0.8–2.1]£ 1.6 [1.1–3.4]*,£ 1.5 [0.9–2.8]*,£ < 0.001
Daily fluid balancea, ml, median [IQR] 3.3 [−612–
605.7]
49.9 [− 521–
650]
105.0 [− 541.3–
780.1]
308.9 [− 171.5–
1123.7]*,$,£
< 0.001
RRT at admission, n (%) 97 (1.6) 22 (5.6)£ 31 (22)*,£ 121 (14.8)*,£ < 0.001
RRT during ICU stay, n (%) 407 (6.5) 48 (12.3)£ 63 (44.7)*,£ 273 (33.4)*,$,£ < 0.001
ICU mortality, n (%) 700 (11.5) 27 (7.1)£ 15 (10.9) 232 (28.9)*,$,£ < 0.001
In non RRT patients, n (%) 580 (10.2) 22 (6.6) 8 (10.7) 102 (19.1)*,£ < 0.001
In RRT patients, n (%) 120 (29.9) 5 (10.9)£ 7 (11.3)£ 130 (48.3)*,$,£ < 0.001
End-of-life decision, n (%) 728 (11.7) 47 (12.1) 12 (8.5) 163 (19.9)*,$,£ < 0.001
In non RRT patients, n (%) 650 (11.1) 43 (12.6) 8 (10.3) 86 (15.8)£ 0.012
In RRT patients, n (%) 78 (19.2) 4 (8.3) 4 (6.3) 77 (28.2)*,$,£ < 0.001
Hospital mortality, n (%) 983 (16.7) 53 (14.7) 33 (24.8)* 296 (37.7)*,$,£ < 0.001
Pairwise p values: *vs transient; $vs prolonged; £vs non-oliguric on admission. aTotal fluid balance divided by the length of ICU stay. IQR interquartile range, RRT
renal replacement therapy, ICU intensive care unit. Percentages are calculated after excluding missing data
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use the more global term of “acute renal failure” (defined
by a renal SOFA score > 2) and need for RRT, because
this puts the degree of renal impairment in relation to
the dysfunction of the other organs. The SOFA criteria
are actually more commonly used than AKI in the crit-
ical care literature [23]. Somewhat surprisingly, in the
current analysis, RRT was used in only 33% of the pa-
tients with permanent oliguria; however, 66% of the pa-
tients with permanent oliguria who did not receive RRT
were discharged to the hospital floor or another hospital
and we have no information about ongoing patient man-
agement after ICU discharge. Patients with permanent
oliguria were also more likely to have a recorded deci-
sion to withhold/withdraw a life-sustaining measure,
possibly explaining why RRT was not used in some of
these patients.
Recovery of a urine output is not itself a predictive fac-
tor, and urine output is not helpful in guiding fluid re-
suscitation [24]. Patients with permanent oliguria had a
more positive fluid balance than those with transient or
prolonged oliguria, which may explain in part the higher
mortality rates in these patients, although it is not pos-
sible to determine whether these observations are epi-
phenomena or causal effects. Vaara et al. demonstrated
an association between cumulative fluid overload (fluid
accumulation > 10%) prior to RRT initiation and in-
creased risk for 90-day mortality; the 90-day mortality
rate of patients with fluid overload was 59.2% versus
31.4% without (difference of 27.8%, p < 0.001) [25]. In
an earlier analysis of the ICON database, we reported
that fluid balances became negative after the third ICU
day in survivors but remained positive in non-survivors
and that higher cumulative fluid balance at day 3 after
ICU admission was independently associated with an in-
crease in the hazard of death [26]. However, large ran-
domized controlled trials have not shown a significant
impact of fluid resuscitation strategy on clinical outcome
or need for RRT [27].
Our study has several strengths but also some limita-
tions. Strengths include the large database with patients
from around the world, providing external validity, and
the collection of data during the ICU stay. Limitations
include the complexity of elements associated with oli-
guria that cannot be separated out, for example, we were
unable to assess the need for fluids or diuretics or to as-
sess the impact of different vasopressors. Moreover, cri-
teria for RRT were not pre-defined due to the study
design. Thus, RRT may have been used for fluid
overload, increased urea and creatinine concentrations,
electrolyte abnormalities, severe acidosis, and any com-
bination of these. Another limitation is the lack of pre-
admission data regarding the length of oliguria prior to
ICU admission or the underlying reason for oliguria as
well as the lack of post-discharge data. The methods of
monitoring urine output and assessing body weight also
likely varied across centers and may have influenced the
accuracy of measurements. Finally, we chose a definition
of oliguria using a cut-off of urine output of 0.5 ml/kg/h,
but this degree of urine output may in fact be adequate
for some patients, e.g., the very obese and the very old.
Conclusion
In conclusion, the present study demonstrates that oli-
guria is a common occurrence in ICU patients, and sug-
gests that it may have a relatively benign nature if only
transient. For prognostic assessment, it is more the dur-
ation of oliguria and need for RRT than oliguria per se
that are associated with a worse outcome.
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Atatürk Educational And Research Hosp. (Atilla Sencan)
Uruguay: CAMS (Silvia M Mareque Gianoni); CASMU (Alberto Deicas); Hospital
Español Asse (Javier Hurtado); Hospital Maciel (Gaston Burghi)
Venezuela: Centro Medico De Caracas (Antonio Martinelli); Hospital Miguel
Perez Carreño (Ingrid Von Der Osten)
Afghanistan: MSF Trauma Hospital Kunduz (Christine Du Maine)
India: Amri Hospitals (Mahuya Bhattacharyya); Amri Hospitals Salt Lake
(Susruta Bandyopadhyay); Apollo Hospital (Srishar Yanamala); Apollo
Hospitals (Palepu Gopal); Apollo Hospitals, Bhubaneswar (Samir Sahu); Apollo
Speciality Hospital (Mohamed Ibrahim); Asian Heart Institute (Darshana
Rathod); Baby Memorial Hospital Ltd., Calicut, Kerala (Nisha Mukundan); Batra
Hospital & Mrc, New Delhi (Arun Dewan); Bombay Hospital Institute of
Medical Sciences (Pravin Amin); Care Hospital (Srinivas Samavedam); Cims
Hospital (Bhagyesh Shah); Columbia Asia Hospital, Mysore (Ganavelu
Gurupal); Dispur Hospitals (Brajendra Lahkar); Fortis Hospital (Amit K Mandal);
Fortis Hospital (Noida) (Mrinal Sircar); Fortis-Escorts Hospital, Faridabad
(Supradip Ghosh); Ganga Medical Centre & Hospital P Ltd. (Veluchamy Bala-
subramani); Hinduja Hospital (Farhad Kapadia); KDAH (Sonali Vadi); Kerala In-
stitute of Medical Sciences (KIMS, RMCC) (Kesavan Nair); Kalinga Institute of
Medical Sciences (KIMS, DTEM) (Swagat Tripathy); Kovai Medical Centre and
Hospital (Sivakumar Nandakumar); Medanta The Medicity, Gurgaon (Jeeten-
dra Sharma); Medica Superspecialty Hospitals (Arindam Kar); Metro Heart In-
stitute with Multispeciality (Simant Jha); Ruby Hall Pune (Kapil Zirpe); Saifee
Hospital (Mayur Patel); Spandan Multispeciality Hospital (Ankur Bhavsar); Tata
Main Hospital (Devi P Samaddar); Tata Memorial Hospital (Atul Kulkarni)
Pakistan: Aga Khan University (Madiha Hashmi); Hearts International Hospital
(Wajid Ali); Liaquat National Hospital (Syed Nadeem)
Sri Lanka: Sri Jayewardenepura General Hospital (Kanishka Indraratna)
Andorra: Hospital Nostra Senyora De Meritxell (Antoni Margarit)
Austria: Akh Wien (Philipp Urbanek); Allgemeines Und Orthopädisches
Landeskrankenhaus Stolzalpe (Joachim Schlieber); Barmherzige Schwestern
Linz (Johann Reisinger); General Hospital Braunau (Johann Auer);
Krankenhaus D. Barmherzigen Schwestern Ried I.I. (Andreas Hartjes);
Krankenhaus Floridsdorf (Andreas Lerche); LK Gmünd-Waidhofen/Thaya-
Zwettl, Standort Zwettl (Thomas Janous); LKH Hörgas-Enzenbach (Eveline
Kink); LKH West (Walter Krahulec); University Hospital (Karl-Heinz Smolle)
Belgium: AZ Groeninge Kortrijk (Marc Van Der Schueren); AZ Jan Palfijn Gent
(Patrick Thibo); AZ Turnhout (Marc Vanhoof); Bracops Anderlecht (Ibis
Ahmet); Centre Hospitalier Mouscron (Philippe Gadisseux); CH Peltzer La
Tourelle (Philippe Dufaye); Chirec Edith Cavell (Olivier Jacobs); CHR Citadelle
(Vincent Fraipont); CHU Charleroi (Patrick Biston); Chu Mont-Godinne (Alain
Dive); CHU Tivoli (Yves Bouckaert); Chwapi (Eric Gilbert); Clinique Saint-Pierre
Ottignies (Benjamin Gressens); Clinique-Maternité Sainte Elisabeth (Eric Pinck);
Cliniques De L’Europe - St-Michel (Vincent Collin); Erasme University Hospital
(Jean-Louis Vincent); Ghent University Hospital (Jan J De Waele); Moliere Hos-
pital (Rocio Rimachi); Notre Dame (Dan Gusu); Onze Lieve Vrouw Ziekenhuis,
Aalst (Koen De Decker); Ixelles Hospital (Kakisidi Mandianga); Sint-Augustinus
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(Luc Heytens); St Luc University Hospital (UCL) (Xavier Wittebole); UZ Brussel
(Herbert Spapen); Vivalia Site De Libramont (Olivier Van Collie); VZW Gezond-
heidszorg Oostkust Knokke-Heist (Wout Vandenheede); ZNA Middelheim
(Peter Rogiers)
Denmark: Herning Hospital (Piotr Kolodzeike); Hjoerring Hospital (Mary Kruse);
Vejle Hospital (Torben Andersen)
Finland: Helsinki University Central Hospital (Veli-Pekka Harjola); Seinäjoki
Central Hospital (Kari Saarinen)
France: Aix Marseille Univ, Hôpital Nord (Marc Leone); Calmette Hospital, Lille
(Alain Durocher); Centre Hospitalier de Dunkerque (Serge Moulront); Centre
Hospitalier Lyon Sud (Alain Lepape); Centre Hospitalo-Universitaire Nancy-
Brabois (Marie-Reine Losser); CH Saint Philibert, Ghicl, Lille (Philippe Cabaret);
CHR De Dax (Evangelos Kalaitzis); CHU Amiens (Elie Zogheib); CHU Dijon
(Philippe Charve); CHU Dupuytren, Limoges (Bruno François); CHU Nîmes
(Jean-Yves Lefrant); Centre Hospitalier De Troyes (Bassam Beilouny); Groupe
Hospitalier Est Francilien-Centre Hospitalier De Meaux (Xavier Forceville);
Groupe Hospitalier Paris Saint Joseph (Benoit Misset); Hopital Antoine Béclère
(Frederic Jacobs); Hopital Edouard Herriot (Bernard Floccard); Hôpital Lariboi-
sère, APHP, Paris France (Didier Payen); Hopital Maison Blanche, Reims (Alain
Wynckel); Hopitaux Universitaires de Strasbourg (Vincent Castelain); Hospices
Civils de Lyon (Alexandre Faure); CHU-Grenoble (Pierre Lavagne); CHU-
Nantes (Thierry Lepoivre); Réanimation Chirurgical Cardiovasculaire, CHRU
Lille (Mouhamed D Moussa); University Hospital Ambroise Paré (Antoine
Vieillard-Baron); University Hospital Grenoble (Michel Durand); University Hos-
pital of Marseille (Marc Gainnier); University of Nice (Carole Ichai)
Germany: Alexianer Krefeld Gmbh (Stefan Arens); Charite Hochschulmedizin
Berlin (Clemens Hoffmann); Charite-University-Hospital, Berlin (Magnus Kaffar-
nik); Diakoniekrankenhaus Henriettenstiftung Gmbh (Claus-Jorg Scharnofske);
Elisabeth-Krankenhaus, Essen (Ingo Voigt); Harlaching Hospital, Munich Muni-
cipal Hospital Group (Claus Peckelsen); Helios St. Johannes Klinik (Matthias
Weber); Hospital St. Georg Leipzig (Jochen Gille); Klinik Hennigsdorf Der
Oberhavel Kliniken Gmbh (Andreas Lange); Klinik Tettnang (Georg Schoser);
Klinikum “St. Georg” Leipzig (Armin Sablotzki); Klinikum Augsburg (Ulrich
Jaschinski); Klinikum Augsburg (Andreas Bluethgen); Klinikum Bremen-Mitte
(Frank Vogel); Klinikum Bremen-Ost (Andreas Tscheu); Klinikum Heidenheim
(Thomas Fuchs); Klinikum Links Der Weser Gmbh (Michael Wattenberg); Klini-
kum Luedenscheid (Torsten Helmes); Krankenhaus Neuwerk (Stefan Scieszka);
Marienkrankenhaus Schwerte (Matthias Heintz); Medical Centre Cologne Mer-
heim (Samir Sakka); Schwarzwald-Baar Klinikum Villingen-Schwenningen
(Johannes Kohler); St. Elisabeth Krankenhaus Köln-Hohenlind (Fritz Fiedler); St.
Martinus Hospital Olpe (Matthias Danz); Uniklinikum Jena (Yasser Sakr); Uni-
versitätsklinikum Tübingen (Reimer Riessen); Universitätsmedizin Mainz
(Thomas Kerz); University Hospital Aachen, CPACC (Alexander Kersten); Uni-
versity Hospital Aachen, DMIII (Frank Tacke); University Hospital Aachen, OIC
(Gernot Marx); University Hospital Muenster (Thomas Volkert); University Med-
ical Centre Freiburg (Axel Schmutz); University Medical Centre Hamburg-
Eppendorf (Axel Nierhaus); University Medical Centre Hamburg-Eppendorf
(Stefan Kluge); University Medicine Greifswald (Peter Abel); University of
Duisburg-Essen (Rolf A Janosi); University of Freiburg (Stefan Utzolino); Uni-
versity clinic Ulm (Hendrik Bracht); Vivantes Klinikum Neukoelln (Susanne
Toussaint)
Greece: Ahepa University Hospital (Maria Giannakou Peftoulidou); Athens
University (Pavlos Myrianthefs); Athens University Medical School (Apostolos
Armaganidis); Evangelismos Hospital (Christina Routsi); General Hospital of
Chania, Crete (Angela Xini); Hippokration General Hospital, Thessaloniki (Eleni
Mouloudi); General hospital of Velos (Ioannis Kokoris); Lamia General Hospital
(George Kyriazopoulos); Naval and Veterans Hospital (Sawas Vlachos);
Papanikolaou General Hospital (Athena Lavrentieva); University Hospital
Alexandroupolis (Panagio Partala); University of Ioannina (George Nakos)
Iceland: Landspitali University Hospital (Alma Moller); Landspitali University
Hospital Fossvogur (Sigurjon Ö Stefansson)
Ireland: Cork University Hospital (Joan Barry); Mercy University Hospital (Ruth
A O’Leary); Mid Western Regional Hospital Complex (Catherine Motherway);
Midland Regional Hospital Mullingar, Co Westmeath (Mohammad Faheem);
St. Vincent’s University Hospital (Eimhin Dunne); Tallaght Hospital (Maria
Donnelly); University Hospital Galway (Torsten Konrad)
Italy: Anesthesiology and Intensive Care (Eleonora Bonora); AO Ospedale
Niguarda Ca′ Granda (Carola Achilli); Azienda Ospedaliera Di Padova (Sandra
Rossi); Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele
(Giacomo Castiglione); Careggi Teaching Hospital (Adriano Peris); Clinicized
Hospital SS Annunziata - Chieti (Daniela Albanese); Fondazione IRCCS Ca′
Granda Ospedale Maggiore Policlinico, Milano; University of Milan (Nino
Stocchetti); H San Gerardo - Monza (Giuseppe Citerio); ICU “Ceccarini”
Hospital Riccione (Lorella Mozzoni); IRCCS Centro Cardiologico Monzino
(Erminio Sisillo); IRCCS Centro Di Riferimento Oncologico Della Basilicata
(Pasquale De Negri); IRCCS Fondazione Ca′ Granda - Ospedale Maggiore
Policlinico (Monica Savioli); Ospedale Belcolle Viterbo (Pietro Vecchiarelli);
Ospedale Civile Maggiore - A.O.U.I Verona (Florin Puflea); Ospedale Civile
Maggiore - A.O.U.I Verona (Vladimir Stankovic); Ospedale Di Circolo E
Fondazione Macchi - Varese (Giulio Minoja); Ospedale Di Trento - Azienda
Provinciale Per I Servizi Sanitari Della Provincia Autonoma Di Trento (Silvia
Montibeller); Ospedale Orlandi (Plinio Calligaro); Ospedale Regionale U.Parini-
Aosta (Raffaella Sorrentino); Ospedale San Donato Arezzo (Marco Feri);
Ospedale San Raffaele (Massimo Zambon); Policlinico G.B. Rossi - A.O.U.I
Verona (Elena Colombaroli); Policlinico University of Palermo (Antonino
Giarratano); Santa Maria Degli Angeli Hospital (Tommaso Pellis); Saronno
Hospital (Carlo Capra); Università Cattolica Del Sacro Cuore (Massimo
Antonelli); University Catania, Italy (Antonino Gullo); University of Florence,
Florence (Cosimo Chelazzi); University of Foggia (Antonella De Capraris);
University of Milano-Bicocca, San Gerardo Hospital (Nicolo Patroniti); Univer-
sity of Modena (Massimo Girardis); University of Siena (Frederico Franchi);
University of Trieste (Giorgio Berlot)
Malta: Mater Dei Hospital (Michael Buttigieg)
Netherlands: Albert Schweitzer Hospital (Hubert Ponssen); Antoni Van
Leeuwenhoek Ziekenhuis (Julia Ten Cate); Atrium Medisch Centrum Parkstad
(Laura Bormans); Bovenij Hospital (Satria Husada); Catharina Hospital
Eindhoven (Marc Buise); Erasmus University Medical Centre (Ben Van Der
Hoven); Martiniziekenhuis Groningen (Auke Reidinga); Medical Centre
Leeuwarden (Michael Kuiper); Radboud University Nijmegen Medical Centre
(Peter Pickkers); Slotervaart Ziekenhuis Amsterdam (Georg Kluge); Spaarne
Ziekenhuis (Sylvia Den Boer); University Medical Centre Utrecht (Jozef
Kesecioglu); Ziekenhuis Rijnstate (Henk Van Leeuwen)
Norway: Haukeland University Hospital (Hans Flaatten); St Olavs Hospital,
Trondheim University Hospital (Skule Mo)
Portugal: Centro Hospitalar Cova Da Beira (Vitor Branco); Centro Hospitalar
Do Porto (Fernando Rua); Centro Hospitalar Do Tâmega E Sousa (Estevao
Lafuente); Centro Hospitalar Gaia/Espinho, Epe (Marta Sousa); Centro
Hospitalar Médio Tejo (Nuno Catorze); Centro Hospitalar Tondela-Viseu (Maria
Barros); Faro Hospital (Luis Pereira); Hospital Curry Cabral (Ana Vintém De Oli-
veira); Hospital Da Luz (Jose Gomes); Hospital De Egas Moniz - Chlo (Isable
Gaspar); Hospital De Santo António, Centro Hospitalar Do Porto (Maria F Per-
eira); Hospital Divino Espírito Santo, Epe (Maria Cymbron); Hospital Espirito
Santo - Évora Epe (Antonio Dias); Hospital Garcia Orta (Eduardo Almeida);
Hospital Geral Centro Hospitalar E Universitario Coimbra (Sofia Beirao); Hos-
pital Prof. Doutor Fernando Fonseca Epe (Isabel Serra); Hospital São Bernardo
(Rosa Ribeiro); Hospital Sao Francisco Xavier, Chlo (Pedro Povoa); Instituto
Portugues De Oncologia Francisco Gentil, Porto (Filomena Faria); Santa Maria
Hospital (Zelia Costa-E-Silva); Serviço De Saúde Da Região Autonóma Da Ma-
deira (Jose J Nóbrega); UCIP (Fatima Fernandes); ULS - Castelo Branco (Joao
Gabriel)
Slovenia: General Hospital Celje (Gorazd Voga); General Hospital Izola (Erik
Rupnik); General Hospital Novo Mesto (Lucka Kosec); Oncological Institute
(Milena Kerin Povšic); Ukc Maribor (Irena Osojnik); University Clinic of
Respiratory and Allergic Diseases (Viktorija Tomic); University Clinical Centre
Maribor (Andreja Sinkovic)
Spain: CH Salamanca (Javier González); Clinic Hospital (Elizabeth Zavala);
Complejo Hospitalario De Jaén (Jesus Pérez Valenzuela); Complejo
Hospitalario De Toledo (Luis Marina); Complexo Hospitalario Universitario De
Ourense (Pablo Vidal-Cortés); Complexo Hospitalario Universitario De Vigo
(Pilar Posada); Corporación Sanitaria Parc Tauli (Ignacio Martin-Loeches); Cruz
Roja Hospital (Noelia Muñoz Guillén); H Vall Hebron (Mercedes Palomar);
HGGC Dr. Negrín (Jordi Sole-Violan); Hospital Clinic (Antoni Torres); Hospital
Clinico San Carlos (Miguel A Gonzalez Gallego); Hospital Clínico Universitario
De Valencia (Gerardo Aguilar); Hospital Clínico Universitario Lozano Blesa (Ra-
quel Montoiro Allué); Hospital Clinico Valencia (Monica Argüeso); Hospital De
La Ribera (Martin Parejo); Hospital De Sagunto (Manuel Palomo Navarro);
Hospital De San Juan De Alicante (Anton Jose); Hospital De Torrejon De
Ardoz (Nicholas Nin); Hospital Del Mar (Francisco Alvarez Lerma); Hospital Del
Tajo (Oscar Martinez); Hospital General Universitario De Elche (Eva Tenza
Lozano); Hospital General Universitario Gregorio Marañon (Sara Arenal
López); Hospital General Universitario Gregorio Marañon (Maria J Perez
Granda); Hospital General Universitario Santa Lucía (Salvador Moreno);
Vincent et al. Critical Care          (2020) 24:171 Page 12 of 14
Hospital Germans Trias I Pujol (Clara Llubia); Hospital Infanta Margarita (Car-
men De La Fuente Martos); Hospital Infanta Sofia (Paloma Gonzalez-Arenas);
Hospital J.M. Morales Meseguer (Noemi Llamas Fernández); Hospital J.M. Mo-
rales Meseguer (Bernard Gil Rueda); Hospital Marina Salu. Denia. Alicante (Isa-
bel Estruch Pons); Hospital Nuestra Señora Del Prado, Talavera De La Reina,
Toledo. España (Nieves Cruza); Hospital San Juan De Dios Aljarafe (Fernando
Maroto); Hospital Sas of Jerez (Angel Estella); Hospital Son Llatzer (Ana Ferrer);
Hospital Universitario Central De Asturias (Lisardo Iglesias Fraile); Hospital Uni-
versitario Central De Asturias (Brigida Quindos); Hospital Universitario De
Alava, Santiago (Amaia Quintano); Hospital Universitario De Basurto, Bilbao
(Maria T Tebar); Hospital Universitario de Getafe (Pablo Cardinal); Hospital
Universitario De La Princesa (Antonio Reyes); Hospital Universitario de Tarra-
gona Joan Xxiii (Alejandro Rodríguez); Hospital Universitario Del Henares
(Ana Abella); Hospital Universitario Fundación Alcorcón (Santiago García Del
Valle); Hospital Universitario La Paz (Santiago Yus); Hospital Universitario La
Paz (Emilio Maseda); Hospital Universitario Rio Hortega (Jose A Berezo); Hos-
pital Universitario San Cecilio (Granada) (Armando Tejero Pedregosa); Hos-
pital Virgen Del Camino (Clara Laplaza); Mutua Terrassa University Hospital
(Ricard Ferrer); Rão Hortega University Hospital (Jesus Rico-Feijoo); Servicio
Andaluz De Salud (Marina Rodríguez); University Okalingaf Navarra (Pablo
Monedero)
Sweden: Karolinska University Hospital And Karolinska Institute (Karin
Eriksson); Sunderby Hospital, Luleå (Dan Lind)
Switzerland: Hôpital Intercantonal De La Broye (David Chabanel); Hôpital
Neuchâtelois - La Chaux-De-Fonds (Hervé Zender); Lindenhofspital (Kuno
Heer); Regionalspital Surselva Ilanz (Gr) Schweiz (Bernd Frankenberger); Uni-
versity Hospital Bern (Stephan Jakob); Zentrum Für Intensivmedizin (Alois
Haller)
United Kingdom: Alexandra Hospital Redditch (Shiju Matthew); Blackpool
Teaching Hospitals (Robert Downes); Brighton And Sussex University
Hospitals (Casiano Barrera Groba); Cambridge University Hospitals NHS
Foundation Trust (Andrew Johnston); Charing Cross Hospital (Roseanne
Meacher); Chelsea & Westminster Hospital (Rick Keays); Christie Foundation
Trust (Philip Haji-Michael); County Hospital, Lincoln (Chris Tyler); Craigavon
Area Hospital (Andrew Ferguson); Cumberland Infirmary (Simon Jones); Dar-
ent Valley Hospital (David Tyl); Dorset County Hospital (Andrew Ball); Ealing
Hospital NHS Trust (John Vogel); Glasgow Royal Infirmary (Malcolm Booth);
Gloucester Royal Hospital (Paul Downie); The Great Western Hospital, Swin-
don (Malcolm Watters); Imperial College Healthcare NHS Trust (Stephen
Brett); Ipswich Hospital NHS Trust (Marc Garfield); James Paget University
Hospital NHS Foundation Trust (Lynn Everett); King’s College Hospital (Sarah
Heenen); King’s Mill Hospital (Sandeep Dhir); Leeds Teaching Hospitals NHS
Trust (Zoe Beardow); Lewisham Healthcare NHS Trust (Marthinus Mostert);
Luton and Dunstable Hospital NHS Trust (Steve Brosnan); Medway Maritime
Hospital (Nuno Pinto); Musgrove Park Hospital (Stephen Harris); Nevill Hall
Hospital (Andy Summors); Pilgrim Hospital (Andrew Norton); Pinderfields
Hospital, Mid Yorkshire NHS Trust (Alastair Rose); Plymouth Hospitals NHS
Trust (Rebecca Appelboam); Princess Royal Hospital Telford (Omubo Davies);
Royal Bournemouth Hospital (Emma Vickers); Royal Free Hampstead NHS
Foundation Trust (Banwari Agarwal); Royal Glamorgan Hospital (Tamas Szak-
many); Royal Hampshire County Hospital (Stephen Wimbush); Royal Liverpool
University Hospital (Ingeborg Welters); Royal London Hospital, Barts Health
NHS Trust (Rupert Pearse); Royal Shrewsbury Hospital (Robin Hollands); Royal
Surrey County Hospital (Justin Kirk-Bayley); St Georges Healthcare (Nick
Fletcher); Surrey & Sussex Healthcare Trust (Barbara Bray); University College
Hospital (David Brealey); University Hospital of South Manchester (Peter
Alexander); Western Infirmary (Steven Henderson); Whittington Hospital
(Chris Hargreaves); Wirral University Teaching Hospital (Heather Black); Yeovil
District Hospital (Kiran Gowda)
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